New York officials file charges against Johnson & Johnson over opioids

Published



The state of New York’s Department of Financial Services has filed charges against Johnson & Johnson, claiming the drugmaker committed insurance fraud by mischaracterizing its opioid products.

The charges announced Thursday are the fourth set the state has filed against opioid manufacturers, according to a news release. DFS is seeking to recover $5,000 plus the amount of the claim per each fraudulent insurance claim submitted.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.